iCAD, Inc. (NASDAQ:ICAD) Short Interest Down 23.1% in February

iCAD, Inc. (NASDAQ:ICAD - Get Free Report) was the recipient of a significant drop in short interest during the month of February. As of February 28th, there was short interest totalling 231,100 shares, a drop of 23.1% from the February 13th total of 300,600 shares. Based on an average daily trading volume, of 444,700 shares, the short-interest ratio is presently 0.5 days. Currently, 0.9% of the shares of the stock are short sold.

iCAD Stock Performance

Shares of iCAD stock traded up $0.08 on Friday, hitting $2.17. 176,079 shares of the company traded hands, compared to its average volume of 250,784. The stock has a market capitalization of $57.46 million, a P/E ratio of -16.65 and a beta of 1.95. iCAD has a 52 week low of $1.18 and a 52 week high of $3.78. The business has a 50-day simple moving average of $2.65 and a 200 day simple moving average of $2.05.

iCAD (NASDAQ:ICAD - Get Free Report) last posted its earnings results on Wednesday, March 19th. The technology company reported ($0.03) earnings per share for the quarter, beating analysts' consensus estimates of ($0.05) by $0.02. iCAD had a negative net margin of 17.81% and a negative return on equity of 15.65%. The firm had revenue of $5.41 million during the quarter, compared to analyst estimates of $4.72 million.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. waypoint wealth counsel grew its holdings in shares of iCAD by 44.0% in the fourth quarter. waypoint wealth counsel now owns 14,400 shares of the technology company's stock valued at $26,000 after purchasing an additional 4,400 shares in the last quarter. Thompson Davis & CO. Inc. purchased a new position in shares of iCAD in the fourth quarter valued at $31,000. PKS Advisory Services LLC purchased a new position in shares of iCAD in the fourth quarter valued at $53,000. Wells Fargo & Company MN grew its holdings in shares of iCAD by 51.3% in the fourth quarter. Wells Fargo & Company MN now owns 39,542 shares of the technology company's stock valued at $72,000 after purchasing an additional 13,402 shares in the last quarter. Finally, Integrated Wealth Concepts LLC purchased a new position in iCAD during the fourth quarter worth $92,000. 24.61% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Wall Street Analysts Forecast Growth

Separately, StockNews.com cut shares of iCAD from a "hold" rating to a "sell" rating in a research report on Tuesday.

iCAD Company Profile

iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.